Picture of BLS Pharmaceuticals logo

BXNDA BLS Pharmaceuticals News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapHigh Flyer

Brief: Bioxyne Says Enters Into Binding Term Sheet To Acquire Breathe Life Sciences

Dec 19 (Reuters) - Bioxyne Ltd  BXN.AX :
    * ENTERS INTO BINDING TERM SHEET TO ACQUIRE  BREATHE LIFE
SCIENCES
PTY LTD
    * CONSIDERATION FOR ACQUISITION WILL BE 1.23 BILLION SHARES
IN BXN

Source text for Eikon:  ID:nASXzBxjB 
Further company coverage:  BXN.AX 
 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on BLS Pharmaceuticals

See all news